Published in J Infect Dis on February 21, 2012
Evaluation of a multiplex assay for estimation of HIV-1 incidence. PLoS One (2013) 0.87
λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein Antibodies. J Infect Dis (2015) 0.78
Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG. Medicine (Baltimore) (2016) 0.76
An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria. PLoS One (2016) 0.75
MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform (2008) 24.69
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08
Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol (1999) 18.82
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (2003) 11.66
Detection of acute infections during HIV testing in North Carolina. N Engl J Med (2005) 7.60
Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses (1995) 7.12
The genetic data environment an expandable GUI for multiple sequence analysis. Comput Appl Biosci (1994) 5.68
Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA (2002) 2.94
Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology (1995) 2.38
Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS (2000) 2.37
Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog (2009) 2.29
Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J Virol (2010) 2.02
Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis (2005) 1.95
A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago. Proc Natl Acad Sci U S A (2000) 1.55
Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection. Clin Infect Dis (2006) 1.43
HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmission. PLoS One (2010) 1.36
Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS (2009) 1.35
Viral load differences in early infection with two HIV-1 subtypes. AIDS (2001) 1.34
Characterization of subtype A HIV-1 from Africa by full genome sequencing. AIDS (1999) 1.31
Identification of inflections in T-cell counts among HIV-1-infected individuals and relationship with progression to clinical AIDS. Proc Natl Acad Sci U S A (1998) 1.14
Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS. J Infect Dis (2004) 1.12
Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa. AIDS Res Hum Retroviruses (2005) 1.03
Genotypic and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive Nigerian patients. AIDS Res Hum Retroviruses (2006) 0.91
High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland. Scand J Infect Dis (2005) 0.90
Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials. Vaccine (2002) 0.90
Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr (2002) 7.79
Naturally acquired simian retrovirus infections in central African hunters. Lancet (2004) 5.34
Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev (2011) 3.63
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retroviruses (2010) 2.86
Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci U S A (2005) 2.86
Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. J Infect Dis (2006) 2.83
Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health (2004) 2.27
Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. AIDS (2002) 1.98
Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006. J Infect Dis (2007) 1.98
Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay. AIDS (2002) 1.96
Prevalences, genotypes, and risk factors for HIV transmission in South America. J Acquir Immune Defic Syndr (2005) 1.82
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204). PLoS One (2011) 1.81
Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol (2012) 1.78
Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PLoS One (2010) 1.77
Early immunological predictors of neurodevelopmental outcomes in HIV-infected children. Clin Infect Dis (2009) 1.68
A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand. AIDS Res Hum Retroviruses (2003) 1.64
Molecular Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina. AIDS Res Hum Retroviruses (2002) 1.50
Identification of new CRF51_01B in Singapore using full genome analysis of three HIV type 1 isolates. AIDS Res Hum Retroviruses (2011) 1.50
Update on HIV-1 diversity in Africa: a decade in review. AIDS Rev (2012) 1.44
Reference values of CD4 T lymphocytes in human immunodeficiency virus-negative adult Nigerians. Clin Diagn Lab Immunol (2005) 1.42
Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited setting. AIDS (2011) 1.41
Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa. Emerg Infect Dis (2010) 1.36
Exposure to nonhuman primates in rural Cameroon. Emerg Infect Dis (2004) 1.35
Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria. PLoS One (2013) 1.30
Preparedness for highly pathogenic avian influenza pandemic in Africa. Emerg Infect Dis (2007) 1.25
African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent. PLoS Med (2008) 1.23
Controlling the last known cluster of Ebola virus disease - Liberia, January-February 2015. MMWR Morb Mortal Wkly Rep (2015) 1.22
Buenos Aires cohort of men who have sex with men: prevalence, incidence, risk factors, and molecular genotyping of HIV type 1. AIDS Res Hum Retroviruses (2007) 1.18
Laboratory-confirmed cholera and rotavirus among patients with acute diarrhea in four hospitals in Haiti, 2012-2013. Am J Trop Med Hyg (2013) 1.17
Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. J Acquir Immune Defic Syndr (2002) 1.16
Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. J Clin Virol (2011) 1.15
Development and characterization of a bead-based, multiplex assay for estimation of recent HIV type 1 infection. AIDS Res Hum Retroviruses (2011) 1.11
Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis (2003) 1.11
Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria. J Acquir Immune Defic Syndr (2015) 1.09
Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria. BMC Infect Dis (2013) 1.08
Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa. AIDS Res Hum Retroviruses (2004) 1.07
Cervical cancer risk factors among HIV-infected Nigerian women. BMC Public Health (2013) 1.07
Screening for hazardous alcohol use and depressive symptomatology among HIV-infected patients in Nigeria: prevalence, predictors, and association with adherence. J Int Assoc Physicians AIDS Care (Chic) (2010) 1.05
First case of HIV Type 1 subtype F among men who have sex with men in Colombia. AIDS Res Hum Retroviruses (2006) 1.04
Simian T-lymphotropic virus diversity among nonhuman primates, Cameroon. Emerg Infect Dis (2009) 1.03
High HIV prevalence and risk factors among injection drug users in Tashkent, Uzbekistan, 2003-2004. Drug Alcohol Depend (2006) 1.03
Epidemiology of human immunodeficiency virus, viral hepatitis (B and C), treponema pallidum, and human T-cell lymphotropic I/II virus among men who have sex with men in Buenos Aires, Argentina. Sex Transm Dis (2006) 1.03
Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms. J Acquir Immune Defic Syndr (2004) 1.01
Utilization of contraception and abortion and its relationship to HIV infection among female sex workers in Tashkent, Uzbekistan. Contraception (2006) 1.00
Timing and determinants of mother-to-child transmission of HIV in Nigeria. Int J Gynaecol Obstet (2009) 1.00
Sequence variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes. AIDS Res Hum Retroviruses (2002) 1.00
Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy. AIDS (2013) 1.00
Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan. AIDS Res Hum Retroviruses (2009) 0.99
Protocol for nearly full-length sequencing of HIV-1 RNA from plasma. PLoS One (2008) 0.99
Identification and genetic characterization of a novel CRF22_01A1 recombinant form of HIV type 1 in Cameroon. AIDS Res Hum Retroviruses (2010) 0.99
Evaluating respondent-driven sampling as an implementation tool for universal coverage of antiretroviral studies among men who have sex with men living with HIV. J Acquir Immune Defic Syndr (2015) 0.99
Genetic characterization of HIV-1 strains circulating in Kazakhstan. J Acquir Immune Defic Syndr (2007) 0.97
A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults. Vaccine (2009) 0.97
Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom. PLoS Negl Trop Dis (2010) 0.97
Social determinants of mixed feeding behavior among HIV-infected mothers in Jos, Nigeria. AIDS Care (2009) 0.96
HIV-1 epidemic in the Caribbean is dominated by subtype B. PLoS One (2009) 0.96
Challenges in treating malignancies in HIV in Nigeria. Curr Opin Oncol (2009) 0.96
Genetic forms of HIV Type 1 in the former Soviet Union dominate the epidemic in Azerbaijan. AIDS Res Hum Retroviruses (2006) 0.95
Breaking community barriers to polio vaccination in Northern Nigeria: the impact of a grass roots mobilization campaign (Majigi). Pathog Glob Health (2012) 0.95
Human immunodeficiency virus type 1 intersubtype recombinants predominate in the AIDS epidemic in Cameroon. New Microbiol (2009) 0.94
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine (2012) 0.94
HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria. AIDS Care (2010) 0.93
Egocentric network data provide additional information for characterizing an individual's HIV risk profile. AIDS (2010) 0.92
Immigration status and HIV-risk related behaviors among female sex workers in South America. AIDS Behav (2007) 0.92
Initiation of a ring approach to infection prevention and control at non-Ebola health care facilities - Liberia, January-February 2015. MMWR Morb Mortal Wkly Rep (2015) 0.92
First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina. Retrovirology (2006) 0.91
Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines. Bull World Health Organ (2003) 0.91
Analysis of protease and reverse transcriptase genes of HIV for antiretroviral drug resistance in Jamaican adults. AIDS Res Hum Retroviruses (2012) 0.90
HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia. AIDS Res Hum Retroviruses (2006) 0.89
HIV type 1 CRF13_cpx revisited: identification of a new sequence from Cameroon and signal for subsubtype J2. AIDS Res Hum Retroviruses (2005) 0.89
The role of hospital-based cancer registries in low and middle income countries-The Nigerian Case Study. Cancer Epidemiol (2012) 0.89
Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J Clin Psychiatry (2012) 0.89
Epidemiological and molecular characteristics of HIV-1 infection among female commercial sex workers, men who have sex with men and people living with AIDS in Paraguay. Rev Soc Bras Med Trop (2008) 0.88
Drug resistance testing provides evidence of the globalization of HIV type 1: a new circulating recombinant form. AIDS Res Hum Retroviruses (2004) 0.88
Elevated hypermutation levels in HIV-1 natural viral suppressors. Virology (2013) 0.88
Human immunodeficiency virus and tuberculosis in Argentina: prevalence, genotypes and risk factors. J Med Microbiol (2008) 0.87
Identification of a novel clade of human immunodeficiency virus type 1 in Democratic Republic of Congo. AIDS Res Hum Retroviruses (2002) 0.87
HIV-1 transgenic rat CD4+ T cells develop decreased CD28 responsiveness and suboptimal Lck tyrosine dephosphorylation following activation. Virology (2006) 0.87
Seroincidence and phylogeny of human immunodeficiency virus infections in a cohort of commercial sex workers in Montevideo, Uruguay. Am J Trop Med Hyg (2005) 0.86
Identification of a possible ancestor of the subtype A1 HIV Type 1 variant circulating in the former Soviet Union. AIDS Res Hum Retroviruses (2008) 0.85
Prevalence and factors associated with human immunodeficiency virus infection among sex workers in Samarkand, Uzbekistan. Sex Transm Dis (2009) 0.85
Altered cord blood gammadelta T cell repertoire in Nigeria: possible impacts of environmental factors on neonatal immunity. Mol Immunol (2008) 0.85
Short report: HIV infection among commercial sex workers and injecting drug users in the Czech Republic. Am J Trop Med Hyg (2006) 0.84
Trends in HIV prevalence among white and African-American civilian applicants for United States Military Service, 1985 to 2003. J Acquir Immune Defic Syndr (2006) 0.84
Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping. AIDS Res Hum Retroviruses (2006) 0.84
HIV-1 infection among civilian applicants for US military service, 1985 to 2000: epidemiology and geography. J Acquir Immune Defic Syndr (2003) 0.84
Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans. AIDS (2003) 0.84